HIV-1 infection substantially increases the risk of developing tuberculosis (TB). Some 42 mechanisms, such as defects in the Th1 response to Mycobacterium tuberculosis (M.tb) in 43
Upon stimulating with mycobacterial antigens, we observed a distinct CD4+ T helper lineage 48 producing IL-22 in the absence of IL-17 and IFN-γ. Th22 cells were present at high 49 frequencies in response to mycobacterial antigens in blood and contributed up to 50% to the 50 CD4+ T cell response to mycobacteria, comparable in magnitude to the IFN-γ Th1 response 51 (median 0.91% and 0.55%, respectively). Phenotypic characterization of Th22 cells revealed 52 that their memory differentiation was similar to M.tb-specific Th1 cells (i.e. predominantly 53 early-differentiated CD45RO+CD27+ phenotype). Moreover, CCR6 and CXCR3 expression 54 profiles of Th22 cells were similar to Th17 cells, while their CCR4 and CCR10 expression 55 patterns displayed an intermediate phenotype between Th1 and Th17 cells. Strikingly, 56 mycobacterial IL-22 responses were three-fold lower in HIV-infected individuals compared 57 to uninfected individuals, and the magnitude of responses correlated inversely with HIV viral 58 load. These data provide important insights into mycobacteria-specific T helper subsets and 59 suggest a potential role for IL-22 in protection against TB during HIV infection. Further 60 studies are needed to fully elucidate the role of IL-22 in protective TB immunity. 61
INTRODUCTION
Participants were >18 years of age, weighed >55 kg, did not have any chronic disease, did 138 not use immunosuppressive medication and were not pregnant or lactating. These studies 139 were approved by the Research Ethics Committee of the University of Cape Town 140 (158/2010, 279/2012). All participants provided written, informed consent. 141 142
Whole blood stimulation assays 143
Venous blood was collected and processed within 4 hours. Whole blood stimulation was 144 performed as previously described (38) 
IL-22 responses are a major component of the CD4+ mycobacterial response 182
We examined CD4+ T cell cytokine profiles in response to a range of mycobacterial antigens 183 in 25 healthy, HIV-uninfected persons sensitized by M. tuberculosis (M.tb IGRA+; Table 1 ). 184 Figure 1A shows representative flow cytometry plots of IFN-γ, IL-22 and IL-17 CD4+ 185 responses to M. bovis BCG, M.tb PPD and a pool of ESAT-6 and CFP-10 peptides from 0.55%, IQR: 0.28-1.46%; Figure 1B) . Remarkably, IL-22 accounted for the greatest 188 proportion of the CD4+ response to BCG (median 0.91%, IQR: 0.52-1.24%). In fact, the 189 frequency of IL-22+ cells was greater than IFN-γ in 75% of participants. responses to BCG were significantly lower (median 0.11%, IQR: 0.06-1.66%) than both IFN-191 γ (p=0.007) and IL-22 (p=0.0008). Stimulation with M.tb PPD led to the detection of a 192 similar IFN-γ response as BCG (median 0.74%), with comparatively lower frequencies of 193 PPD-specific IL-22+ CD4+ T cells (median 0.21%; p=0.02) and IL-17+ cells (median 0%; 194 p<0.0001) ( Figure 1B) . The ESAT-6/CFP-10 response was dominated by IFN-γ (median 195 0.07%), with low to undetectable IL-17 and IL-22 responses (medians of 0%). Taken 196 together, these data demonstrate that different mycobacterial antigen preparations result in 197 detection of different CD4+ T cell cytokine profiles. Of note, IL-22 made a substantial 198 contribution to the anti-mycobacterial CD4+ response, with responses equivalent to or greater 199 than the IFN-γ response to BCG. 200 201
Most CD4+ T cells producing IL-22 do not make IFN-γ and IL-17 202
We next focused on the high magnitude IL-22 response detected to BCG, to further 203 characterize IL-22 CD4+ responses and their relationship with IFN-γ and IL-17. There was a 204 highly significant positive correlation between IFN-γ and IL-22 responses to BCG (p<0.0001, 205 r=0.830; Figure 2A ). The frequency of IL-17+ CD4+ T cells also correlated with both IFN-γ 206 and IL-22 production (p=0.039, r=0.424 and p=0.005, r=0.559, respectively; data not shown). 207
Given these associations between IFN-γ, IL-22 and IL-17, we examined the co-expression 208 patterns of the cytokines following BCG stimulation ( Figure 2B) . The majority of BCG-209 responding CD4+ T cells produced only IL-22 (median 47%; IQR: 36.6-59.6), whilst CD4+ 210 cells secreting IFN-γ-alone made up a median of 37% (IQR: 27.1-47.4). There was minimal 211 co-expression of IL-22 with both IL-17 (median 0.5%) and with IFN-γ (median 6.4%). When 212 examining all CD4+ T cells producing IL-22, a median of 78% produced IL-22 alone (IQR: 213 71.1-89.2%), while 14% and 1.5% co-expressed IFN-γ or IL-17, respectively (data not 214 shown). We also investigated IL-22 production in combination with other cytokines and 215 found low or negligible co-expression with TNF-α, IL-2 and IL-21 (medians 0.3%, 0.5% and 216 3%, respectively, data not shown). Our data reveal that the large proportion of BCG-specific 217 IL-22 was produced predominantly by CD4+ T cells secreting IL-22 in the absence of either 218 IL-17 or IFN-γ, consistent with being a distinct 'Th22' lineage (28-30). 219 220
Phenotypic characteristics of mycobacteria-specific IL-22-producing CD4+ T cells 221
In order to characterize the Th22 subset in more detail, we determined the memory 222 differentiation profile of mycobacteria-specific Th22 cells (i.e. those producing IL-22 alone) 223 compared to cells producing only IFN-γ or IL-17. Figure 3A To further characterize the phenotype of the different cytokine-producing subsets, we 234 examined chemokine receptor expression profiles on CD4+ cells producing IFN-γ, IL-22 or 235 IL-17. For these studies, we stimulated whole blood with M.tb whole cell lysate. To ensure 236 that we were measuring similar cytokine responses, we compared IFN-γ, IL-22 and IL-17 237 induced by each antigen and found highly comparable frequencies of CD4+ T cell responses 238 in the same donors (Supplemental Figure S1 ). Figure 4A shows representative flow 239 cytometry plots of M.tb-specific CD4+ T cell production of IFN-γ, IL-22 and IL-17 overlaid 240 onto chemokine receptor expression profiles (CXCR3, CCR6, CCR4 and CCR10). Whilst a 241 majority of IFN-γ-producing cells expressed CXCR3 (median 61.5%), a sizable fraction also 242 expressed CCR6 (median 54.5%), with a low proportion expressing CCR4 (median 4.1%) 243 and negligible CCR10 (median 0.5%; Figure 4B ). In contrast, CD4+ cells producing IL-22 244 were almost all CCR6 positive (median 94.7%), and compared to cells producing IFN-γ, 245 significantly fewer expressed CXCR3 (median 27.7%), and significantly more expressed 246 CCR4 and CCR10 (median 23.3% and 2.7%, respectively). Th17 cells (IL-17+) shared 247 comparable expression profiles for CCR6 and CXCR3 (medians 96.1% and 17.2%, 248 respectively), but a higher proportion expressed CCR4 (median 50.8%) and CCR10 (median 249 5.8%) compared to Th22 cells. Of note, cells co-producing IFN-γ and IL-22 had a similarly 250 high expression of CCR6 as Th22 and Th17 cells, but were otherwise intermediate between 251 Figure S2A) . These 252 findings demonstrate distinct patterns of chemokine receptor expression on different 253 cytokine-producing subsets. These data are consistent with previous descriptions (28, 30), but 254 also highlight the substantial overlap in chemokine receptor expression between T helper 255 subsets producing distinct cytokines. 256
IFN-γ+ and Th22 for the remaining chemokine receptors (Supplemental
We also investigated the homing potential of M.tb-specific CD4+ Th subsets using 257 KLRG1 and CD26. Killer cell lectin-like receptor G1 (KLRG1)-expressing cells appear to be 258 retained within lung blood vasculature, while KLRG1 − cells migrate to the lung parenchyma 259 (40). Dipeptidyl peptidase IV (CD26) is involved in enzymatic chemokine modification that 260 enhances T cell migration (41, 42). Expression of these markers was significantly different 261 between Th subsets (Supplementary Figure S2B) . Th22 cells were characterized by a near 262 absence of KLRG1 expression compared to Th1 and Th17 cells. In contrast, 50% of Th22 263 cells expressed CD26, compared to a median of 34% of Th1 cells and 11% of Th17 cells 264 (Supplemental Figure S2B) . These data suggest that M.tb-specific Th22 are endowed with a 265 distinct homing potential compare to Th1 and Th17 cells. with a median CD4 count of 619 cells/mm 3 (IQR: 532.5-782) and a median plasma viral load 272 of 6.38 x10 3 copies/ml (IQR: 3.55-16.45 x10 3 ; Table 1 ). Consistent with previous reports, the 273 frequency of M.tb-specific CD4+ T cells producing IFN-γ was significantly lower in HIV-274 infected participants compared to uninfected participants in response to BCG (p=0.0004, 275 medians 0.12% and 0.55%, respectively; Figure 5A) . Notably, the IL-22 response to BCG 276 was also lower in HIV-infected individuals, to a similar degree as the IFN-γ response 277 (p=0.0005; medians 0.28% and 0.91%, respectively). Additionally, IL-17 responses were also 278 significantly lower in HIV-infected individuals in response to BCG compared to the HIV-279 uninfected group (p<0.0001, medians 0% and 0.11%, respectively). After adjusting for CD4 280 count, these differences became even more evident (Figure 5B) , despite the relatively well-281 preserved CD4+ T cell numbers in our HIV-infected cohort. HIV-infected participants had 8-282 fold (p<0.0001) and 3-fold (p=0.0003) fewer CD4+ T cells producing IFN-γ or IL-22, 283 respectively, compared to uninfected participants. There were also fewer cells producing IL-284 17 in HIV-infected individuals (median 0; p<0.0001). Similar results were obtained for IFN-γ 285 and IL-22 in response to PPD (Supplemental Figure S3A We thank the study participants for providing samples and for their time and commitment to 426 the study, and to the clinical staff at the Ubuntu HIV-TB clinic. We thank Dr Shaun Barnabas 427 and Rene Goliath for phlebotomy. We thank Mrs Kathryn Norman for administrative 428 assistance. We are grateful to BEI Resources, NIAID, NIH, for the following reagent: 429 IFNγ-secreting cells but is dispensable for host protection against Mycobacterium 
